INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $712 | -18.7% | 22,531 | +4.8% | 0.01% | -16.7% |
| Q2 2023 | $876 | +7.7% | 21,492 | -1.5% | 0.01% | +20.0% |
| Q1 2023 | $813 | +12.9% | 21,815 | +5.7% | 0.01% | 0.0% |
| Q4 2022 | $720 | -99.9% | 20,644 | -7.3% | 0.01% | -44.4% |
| Q3 2022 | $1,246,000 | +124.1% | 22,273 | +107.4% | 0.01% | +125.0% |
| Q2 2022 | $556,000 | -45.3% | 10,739 | -23.3% | 0.00% | -20.0% |
| Q1 2022 | $1,017,000 | -32.5% | 13,994 | +9.8% | 0.01% | -28.6% |
| Q4 2021 | $1,507,000 | +16.0% | 12,747 | +31.7% | 0.01% | 0.0% |
| Q3 2021 | $1,299,000 | +0.8% | 9,681 | +21.6% | 0.01% | 0.0% |
| Q2 2021 | $1,289,000 | +214.4% | 7,962 | +55.8% | 0.01% | +250.0% |
| Q1 2021 | $410,000 | +82.2% | 5,110 | +23.5% | 0.00% | +100.0% |
| Q4 2020 | $225,000 | – | 4,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |